Malcolm Rossi
Dr. Ross has over 35 years experience in the Generics Industry, the last 15 being at corporate level. He has been intimately involved in strategic planning, pipeline management and related activities. His early industrial experience with Teva and Taro were directed primarily to the US markets but later, as President of IPR, a company jointly […]
Ziyaur Rahman
Dr. Ziyaur Rahman received his Ph.D. in pharmaceutics from Hamdard University in 2005. Dr. Rahman joined the Pharmaceutical Sciences Department at Texas A&M University as an Associate Professor in 2016. Dr. Rahman teaches Pharmaceutics and Pharmaceutical Calculations courses to PharmD students, and Advance physical pharmacy to graduate students. Dr. Rahman’s research focuses are on formulation […]
Successful Mitigation Strategies for Nitrosamines
